FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for omeprazole by Sandoz Inc (ANDA 076515).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)